Weekly roundup: MDR certificate granted for Biocomposites and ‘Dealmakers’ highlights
Biocomposites gains MDR certification for STIMULAN® Rapid Cure and STIMULAN® Kit
Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, has secured European Union Medical Device Regulation (MDR) certification for its STIMULAN® products. The approval confirms that STIMULAN® can be mixed with vancomycin, gentamicin and tobramycin, and the combination of vancomycin with either tobramycin or gentamicin, to assist in the treatment of infection in bone and surrounding soft tissue.
📺Optimum TV
If you missed Optimum TV’s ‘Dealmakers 2026’ series, we’ve made it easier than ever to catch up in quick, bitesize highlights.
We’ve released five short clips showcasing standout moments from each fantastic episode, now live on our YouTube channel. Watch the highlights here.
Prefer the full experience? Dive straight into the full-length episodes here.
👥Industry events
Optimum’s Stephen Adams chaired the Increasing Engagement and Communication panel at yesterday’s Bionow BioInfect 2026 conference.
The conference delivered great insights into the future of Antimicrobial Resistance (AMR) and the escalating global challenge it presents, making for a truly impactful and thought-provoking day.
BIO-Europe Spring
Optimum’s CEO Mary Clark and Associate Director Zoe Bolt will be in Lisbon from 23rd-25th March the EBD’s Spring edition of BIO-Europe.
The team are looking forward to a week of meaningful connections and innovation. Please reach out to connect with them there 🤝
🧩Sector moves
Keep up to date with the latest industry moves here.
That’s all folks! To stay in the know – subscribe to Optimum’s weekly wrap-up today!
